Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.0575    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.005 (9.091%)
Market Cap: £3.29m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Convertible Note Amendment

14 Apr 2026 13:51

RNS Number : 4455A
Empyrean Energy PLC
14 April 2026
 

 

14 April 2026

This announcement contains inside information

 

Empyrean Energy PLC / Index: AIM / Epic: EME / Sector: Oil & Gas

 

Convertible Note Amendment

 

Empyrean Energy plc ("Empyrean" or the "Company"), the oil and gas exploration and development company with interests in Australia, Indonesia, and the United States is pleased to announce that it has reached agreement to amend key terms under its existing Convertible Note.

 

Background

 

In December 2021, the Company announced that it had entered into a Convertible Loan Note Agreement with a Melbourne-based investment fund (the "Lender"), pursuant to which the Company issued a convertible loan note to the Lender and received gross proceeds of £4.0 million (the "Convertible Note").

 

As announced in May 2022, the Company and the Lender then amended the key repayment terms of the Convertible Note, which at that time included the right by the Lender to redeem the Convertible Note within 5 business days of the announcement of the results of the Jade well at Block 29/11. The face value of the Convertible Note, including accrued interest, was reset to £3.3 million with interest to commence and accrue at £330,000 per calendar month from 1 December 2022.

 

As announced in May 2023, the Company and the Lender reached agreement to amend further key terms including a reduction in the face value of the Convertible Note from £5.28 million (including interest accrued to the end of May 2023) to £4.6 million. It was also agreed with the Lender that no interest would accrue on the Convertible Note until 31 December 2023, with interest accruing thereafter at a rate of 20% p.a. At that time, the conversion price on the Convertible Note was also reduced from 8p to 2.5p per Share. The agreed terms provided that upon a successful sale of the Company's interest in Mako, Empyrean must redeem the face value of the Convertible Note and pay the Lender the greater of (a) US$1.5 million or (b) 15% of the proceeds such sale.

 

Changes Effective 1 April 2026

 

As announced in February 2026, Empyrean, Conrad Asia Energy Ltd ("Conrad"), and its subsidiary, West Natuna Exploration Limited ("WNEL") executed a detailed Shareholders Agreement ("SHA") which governs the ongoing relationship between Conrad and Empyrean moving forward and also defined Empyrean's participation in the Mako Project within a Special Purpose Vehicle ("SPV"). Under these agreements, Empyrean is entitled to 8.5% of all cash payments to WNEL including revenue from gas sales from the Mako Gas Project in Indonesia ("Mako Project"). The agreements are subject to customary conditions precedent, including approval from Indonesia's Ministry of Energy and Mineral Resources.

 

In parallel with the restructure of Empyrean's participation in the Mako Project, Empyrean has also been in discussions with the Lender with regards to the Convertible Note, with the parties having now reached agreement on the amended key terms to the Convertible Note, as follows:

 

1. The interest on the Convertible Note (which has a face value £6.7m including interest accrued to the end of March 2026) has been decreased from 20% per annum to 5% per annum for the period 1 April 2026 to 30 September 2026, with interest then reverting to 20% per annum from 1 October 2026.

2. Empyrean is to maintain a minimum cash balance of £1.25 million until such time as the Convertible Note is repaid.

 

All other terms of the Convertible Note and previous amendments remain in place.

 

Empyrean CEO & Technical Director, Gaz Bisht, commented:

 

"This is a constructive and important step for Empyrean. The significant reduction in the interest payable on the note over the next 6 months preserves the Company's working capital while it assesses new acquisition opportunities in the oil and gas sector and as the Mako Project is developed.

 

We appreciate the continued support of our Lender and remain focused on delivering a broader balance sheet solution and unlocking value, particularly in relation to the Mako Project.

 

As recently announced, Empyrean secured its ongoing participation in the Mako Project through an SPV, which necessitated discussions with the Lender as to any potential impact this has on the Convertible Note.

 

With cash payments of approximately $US 0.76 million due from WNEL in the coming months (less the negotiated cash call payment of US$0.35m) and existing free cash of $US 2.37 million (£1.76 million) at 31 March 2026 (unaudited), the Company believes it has adequate working capital for a minimum of 18 months. Further, should a compelling new opportunity present itself the Lender has indicated that it is open to discussions on revisiting the minimum cash balance requirement, if it is agreed that part of those funds would be better used toward a value accretive opportunity".

 

For further information please visit www.empyreanenergy.com or contact the following:

 

Empyrean Energy plc

Tel: +61 (8) 6146 5325

Gaz Bisht

Cavendish Capital Markets Limited (Nominated Advisor and Broker)

Tel: +44 (0) 207 220 0500

Neil McDonald

Pearl Kellie

AlbR Capital Limited (Joint Broker)

Tel: +44 (0)20 7469 0930

Colin Rowbury

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLZLFFQZLZBBD
Date   Source Headline
5th Feb 20252:47 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNS£675,000 Placing
28th Jan 20253:39 pmRNSHolding(s) in Company
28th Jan 20257:50 amRNSLand access agreement for Wilson River 1 secured
23rd Jan 20257:00 amRNSParticipation option in the Wilson River prospect
6th Jan 20257:00 amRNSHolding(s) in Company
18th Dec 20247:00 amRNSInterim Results
4th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:14 pmRNSResults of General Meeting
13th Nov 20247:00 amRNSPosting of Circular
12th Nov 20249:00 amRNSChange of Registered Office Address
11th Nov 202410:15 amRNSResults of Retail Offer
6th Nov 20247:22 amRNSRetail Offer
6th Nov 20247:00 amRNSProposed Fundraise and Capital Reorganisation
28th Oct 202412:11 pmRNSResults of General Meeting
8th Oct 20249:19 amRNSHolding(s) in Company
2nd Oct 202411:05 amRNSPosting of Annual Report and Notice of GM
1st Oct 20247:00 amRNSFinal Results
30th Sep 202410:48 amRNSResult of AGM
19th Sep 20244:14 pmRNSHolding(s) in Company
4th Sep 20241:36 pmRNSPosting of Notice of Annual General Meeting
2nd Sep 20247:00 amRNSGas Sale Agreement Signed with Sembcorp
22nd Aug 20249:02 amRNSBoard Restructure
26th Jul 20248:30 amRNSIssue of Salary Sacrifice Shares
24th Jun 20247:00 amRNSMako Binding Gas Sale Agreement Signed with PGN
13th Jun 20247:00 amRNSBlock 29/11 China update
5th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:57 amRNSMako Gas Sale Key Terms Signed with PGN
23rd Feb 20247:39 amRNSMinisterial Approval of Mako Gas Price
13th Feb 20247:00 amRNSEmpyrean completes £700,000 Placing
31st Jan 20247:00 amRNSDuyung PSC Update
18th Dec 202311:34 amRNSInterim Results
20th Nov 20232:40 pmRNSChange of Nominated Adviser
27th Sep 202312:58 pmRNSResult of AGM
15th Sep 20237:00 amRNSIssue of Salary Sacrifice Shares
12th Sep 20237:13 amRNSKey Terms Agreed for Long-Term Gas Sales Agreement
4th Sep 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Sep 202312:30 pmRNSFinal Results
30th May 20237:36 amRNSCapital raising, Debt Restructure & Company Update
2nd May 20237:00 amRNSMako gas field - Update
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSInterim Results
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSMako Gas - Approval of Updated Plan of Development
19th Oct 20221:19 pmRNSResults of General Meeting
27th Sep 202212:54 pmRNSResult of AGM
26th Sep 202212:01 pmRNSPosting of Annual Report and Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.